Nectar
New York City, US · 9 known investors
Nectar Allergy & Asthma is an allergy care platform offering testing, diagnosis, and treatment for food and environmental allergies, asthma, and eczema, including at-home testing kits and custom sublingual immunotherapy drops. It serves patients through in-person clinics in New York City and an online platform for at-home care across most U.S. states.
Digital HealthDirect to ConsumerHealthtech
Founders & leadership
HP
Hersh PatelFounder
Investors · 9
Gold House VenturesCovina · $100K – $1M
Harmony PartnersNew York
Obvious VenturesSan Francisco · $250K – $6M
GV (Google Ventures)reported · 2 sourcesMountain View · $250K – $50M
Menlo Venturesreported · 2 sourcesSan Francisco · $1M – $20M
Mercury FundreportedHouston · $250K – $4M
True Venturesreported · 2 sourcesSan Francisco · $500K – $3M
Trust FundreportedLos Angeles · $2K – $20K
Also in the syndicate · 1
Flying Fish
In the news
Frequently asked questions
- What does Nectar do?
- Nectar Allergy & Asthma is an allergy care platform offering testing, diagnosis, and treatment for food and environmental allergies, asthma, and eczema, including at-home testing kits and custom sublingual immunotherapy drops. It serves patients through in-person clinics in New York City and an online platform for at-home care across most U.S. states.
- Who are Nectar's investors?
- Nectar's investors include Gold House Ventures, Harmony Partners, Obvious Ventures, GV (Google Ventures), Menlo Ventures, Mercury Fund, True Ventures, Trust Fund.
- Where is Nectar headquartered?
- Nectar is headquartered in New York City, US.